Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ United Labels Kaufen (DPA-AFX) +++ UNITED LABELS Aktie -5,81%

IRLAB Aktie

>IRLAB Performance
1 Woche: 0%
1 Monat: -6,2%
3 Monate: -13,1%
6 Monate: -30,3%
1 Jahr: -43,5%
laufendes Jahr: -30,3%
>IRLAB Aktie
Name:  IRLAB THERAP. AB A
Land:  Schweden
Sektor:  Gesundheit
ISIN/ Wkn:  SE0012675361 / A2PLBE
Symbol/ Ticker:  6IRA (Frankfurt)
Kürzel:  FRA:6IRA, ETR:6IRA, 6IRA:GR
Index:  -
Webseite:  https://www.irlab.se/
Marktkapitalisierung:  33 Mio. EUR
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  42.59 / -
KUV/ KBV/ PEG:  3.52 / 75.19 / -
Gewinnm./ Eigenkapitalr.:  - / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  IRLAB
Letzte Datenerhebung:  03.07.25
>IRLAB Eigentümer
Aktien: -
f.h. Aktien: -
Insider Eigner: -
Instit. Eigner: -
Leerverk. Aktien: -
>IRLAB Peer Group

 
11.06.25 - 18:54
 Report from the Annual General Meeting 2025 of IRLAB Therapeutics AB (Accesswire)
 
GOTHENBURG, SWEDEN / ACCESS Newswire / June 11, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Today, on Wednesday June 11, 2025, IRLAB Therapeutics AB held its Annual General Meeting.The foll......
04.06.25 - 07:27
 IRLAB Therapeutics: IRLAB Participates in Aktiespararna′s Event - Aktiedagarna (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / June 4, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, June 4, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discov......
28.05.25 - 07:30
 IRLAB Therapeutics: IRLAB Reports Positive Results from the Second Part of a Phase I Study with IRL757 (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / May 28, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 28, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company that di......
15.05.25 - 07:30
 IRLAB Therapeutics: IRLAB to Present at BioStock Global Forum 2025 (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / May 15, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 15, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company that di......
13.05.25 - 07:30
 IRLAB Therapeutics: IRLAB is Granted a Patent Expanding the Patent Protection for the Drug Candidate Mesdopetam in the US (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / May 13, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 13, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discov......
12.05.25 - 09:06
 Notice to the Annual General Meeting in IRLAB Therapeutics AB (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / May 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - IRLAB Therapeutics AB, reg. no. 556931-4692 ("IRLAB" or the "Company"), holds its Annual General Meeti......
07.05.25 - 07:30
 IRLAB Therapeutics: IRLAB Publishes Interim Report for the Period January - March 2025 (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / May 7, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced tha......
06.05.25 - 07:30
 IRLAB Therapeutics: IRLAB: Invitation to the Interim Report for Q1 2025 Presentation and Webcast (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / May 6, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 6, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discover......
25.04.25 - 22:06
 IRLAB Therapeutics: IRLAB publishes the Annual Report for 2024 (Accesswire)
 
GOTHENBURG, SWEDEN / ACCESS Newswire / April 25, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, April 25, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company......
07.04.25 - 07:30
 IRLAB Therapeutics: IRLAB Presents at Two Redeye Events (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / April 7, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announces t......
01.04.25 - 07:30
 IRLAB Therapeutics: IRLAB to Present Clinical and Preclinical Data at the AD/PD 2025: 19th International Conference on Alzheimer′s & Parkinson′s Diseases (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / April 1, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, April 1, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company disc......
28.03.25 - 07:30
 IRLAB Therapeutics: IRLAB Provides Additional Efficacy Data from the Phase IIb Study of Pirepemat in Patients with Parkinson′s Disease (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / March 28, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, March 28, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that......
27.03.25 - 07:30
 IRLAB Therapeutics: IRLAB to Initiate a Study of IRL757 in Parkinsons′s Disease with Full Financial Backing from its Development Partner MSRD (Accesswire)
 
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY. GOTHENBURG, SE / ACCESS Newswire / March 27, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a c......
12.03.25 - 08:09
 IRLAB Therapeutics: IRLAB Publishes Preclinical Data on mesdopetam in the Esteemed European Journal of Neuroscience (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering ......
11.03.25 - 07:30
 IRLAB Therapeutics: IRLAB Participates in Stora Aktiedagarna (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / March 11, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)(Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disea......
05.03.25 - 14:30
 IRLAB Therapeutics: IRLAB Reports Topline Results from a Phase IIb Study of Pirepemat in Patients with Parkinson′s Disease (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / March 5, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)(Nasdaq Stockholm:IRLAB A), a company that discovers and develops new treatments for Parkinson's disease......
27.02.25 - 07:30
 IRLAB Therapeutics: IRLAB Publishes Phase IIb Data on Mesdopetam in Movement Disorders Clinical Practice (Accesswire)
 
GOTHENBURG, SWEDEN / ACCESS Newswire / February 27, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a co......
20.02.25 - 07:27
 IRLAB Therapeutics: IRLAB Receives Positive Feedback from EMA Confirming Alignment with FDA on Phase III Program for Mesdopetam (Accesswire)
 
GOTHENBURG, SWEDEN / ACCESS Newswire / February 20, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 20 February, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB a compan......
18.02.25 - 01:27
 IRLAB Therapeutics: IRLAB Strengthens Its Value Creation Capabilities Through Extended And Expanded Debt Financing (Accesswire)
 
GOTHENBURG, SWEDEN / ACCESS Newswire / February 17, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)/ IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel t......
12.02.25 - 07:30
 IRLAB Therapeutics: IRLAB Publishes Full-Year Report for 2024 (Accesswire)
 
GOTHENBURG, SE / ACCESS Newswire / February 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 12, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a compan......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der guckt die Bälle weg. - Fritz Walter
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!